Robotic Assistance Devices, Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc., is proud to announce the launch of AVA™ (Autonomous Verified Access) Gen 4, ...

Reports Q4 revenue $667.5M, consensus $679.75M. Norman Schwartz, Bio-Rad’s (BIO) Chairman and CEO, commented: “Bio-Rad demonstrated ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ...

HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO) reported fourth-quarter results that fell short of analyst ...

Edward Chung; Vice President - Investor Relations; Bio Rad Laboratories Inc. Unidentified Company Representative. Roop Lakkaraju; Chief Financial Officer, Executive ...

C-Rad AB (FRA:24C) reports strong profitability and APAC expansion amid macroeconomic headwinds and order cancellations.

This is an important and solid study that examines the role of TFAM, a protein that helps maintain mtDNA, in mtDNA mutator mice. The authors have demonstrated that TFAM's counteractive role in mtDNA ...

Sovereign Remedies founder Charlie Hodge has sold the upscale craft cocktail bar to a collective of service industry workers: ...

Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year ...

In other trial news, genetic medicine house PYC Therapeutics (ASX:PYC) has been given the go-ahead to start a local trial of ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ ...